Shannon Westin
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Shannon Westin
Mar 26, 2024, 09:45 |
Insight
Shannon Westin: Overall survival is improved in all comers in the RUBY study of Immunotherapy and chemotherapy in advanced/recurrent Endometrial Cancer
Shannon Westin, Professor at Department of Gynecologic Oncology and Reproductive Medicine at The University of…
Feb 29, 2024, 14:13 |
Blog
Eric Rios-Doria: How to take your social media to the next level
Eric Rios-Doria, Gynecologic Oncology Fellow at University of Washington Medical Center, shared a post on…
Nov 14, 2023, 04:17 |
Career
Shannon Westin: It’s my great pleasure to be a volunteer for this awesome society (ASCO)!
Shannon Westin, Professor at Department of Gynecologic Oncology and Reproductive Medicine at The University of…
Nov 10, 2023, 17:35 |
Positive
Shannon Westin: Full disclosure - he is my better half!
Shannon Westin, Professor at Department of Gynecologic Oncology and Reproductive Medicine at The University of…
Oct 24, 2023, 13:44 |
Insight
MD Anderson-led global Phase III study finds that a PARP inhibitor plus immunotherapy lowers the risk of endometrial cancer progression over chemotherapy alone - MD Anderson Cancer Center
All:
5
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube